RHHBY - Roche Holding AG

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201612/31/201512/31/201412/31/2013
Total Revenue52,636,00050,403,00049,866,00048,612,000
Cost of Revenue15,106,00014,254,00012,978,00012,379,000
Gross Profit37,530,00036,149,00036,888,00036,233,000
Operating Expenses
Research Development----
Selling General and Administrative----
Non Recurring----
Others----
Total Operating Expenses35,821,00034,954,00033,356,00032,003,000
Operating Income or Loss16,815,00015,449,00016,510,00016,609,000
Income from Continuing Operations
Total Other Income/Expenses Net----
Earnings Before Interest and Taxes16,815,00015,449,00016,510,00016,609,000
Interest Expense-707,000-885,000-946,000-1,085,000
Income Before Tax----
Income Tax Expense3,274,0002,931,0002,980,0003,304,000
Minority Interest----
Net Income From Continuing Ops----
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income9,576,0008,863,0009,332,00011,164,000
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares----